Genomic Vision SA banner

Genomic Vision SA
PAR:GV

Watchlist Manager
Genomic Vision SA Logo
Genomic Vision SA
PAR:GV
Watchlist
Price: 0.0018 EUR
Market Cap: €694.6k

Wall Street
Price Targets

GV Price Targets Summary
Genomic Vision SA

There are no price targets for GV.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Genomic Vision SA Competitors:
Price Targets
BRI
Britania PCL
10% Upside
VINP
Vinci Partners Investments Ltd
36% Upside
PTGX
Protagonist Therapeutics Inc
10% Upside

Revenue
Forecast

-14% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss
-14% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss

For the last 8 years the compound annual growth rate for Genomic Vision SA's revenue is -14%. The projected CAGR for the next 4 years is 19%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-99%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-99%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GV's stock price target?
Not Available

GV doesn't have any price targets made by Wall Street professionals.

What is Genomic Vision SA's Revenue forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Genomic Vision SA's revenue is -14%. The projected CAGR for the next 4 years is 19%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett